Published in J Immunol Methods on January 01, 1976
Retracted Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia. J Clin Invest (1980) 1.19
Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virus. Infect Immun (1978) 0.80
Inhibitory effects of peripheral blood cells on in vitro colony formation by autologous bone marrow in aplastic anaemia: relation with response to immunosuppressive therapy. J Clin Pathol (1982) 0.75
The effect of the plant lectins phytohaemagglutinin and concanavalin A on human T cell populations bearing receptors for IgG and IgM. Clin Exp Immunol (1980) 0.75
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications. Leukemia (2006) 1.74
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. Br J Anaesth (1999) 1.53
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol Immunother (1992) 1.45
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol (2000) 1.22
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol (2005) 1.08
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Interferon enhances the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes. J Immunol (1981) 1.04
Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival. Br J Cancer (2002) 1.00
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood (2000) 0.99
Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol (1987) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis (2000) 0.97
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
[Blood transfusion increases the risk of surgical infection]. Ugeskr Laeger (1993) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood (1984) 0.96
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med (1991) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Characterization of murine dendritic cells derived from adherent blood mononuclear cells in vitro. Scand J Immunol (2000) 0.93
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leuk Res (1984) 0.91
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols. Scand J Immunol (2003) 0.90
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol (1985) 0.89
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89
Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trial. Br J Cancer (2006) 0.89
Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer (1999) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
[Extramedullary manifestations among adult patients with acute lymphoblastic leukemia (ALL)]. Ugeskr Laeger (1991) 0.88
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. Leukemia (2013) 0.87
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. In Vivo (1999) 0.87
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg (1997) 0.86